
Neurogenetics Publications
NYU Langone’s Division of Neurogenetics faculty publish frequently in prestigious, peer-reviewed journals. Here is a selection of their recent publications.
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Nature medicine. 2025 Apr 16;
NDUFS8-Related Leigh Syndrome Mimicking a Leukodystrophy
Journal of child neurology. 2025 Apr 16; 8830738251328199
Acute Effects of Pediatric Primary Brain Tumors
Pediatric neurology. 2025 Mar 22; 167:60-65
Estimating health state utilities for aromatic L-amino acid decarboxylase deficiency (AADCd) in the United States
Health & quality of life outcomes. 2025 Jan 23; 23:7
Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
Pediatric dermatology. 2025 Nov ; 42:67-72
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial
Neuro-oncology. 2024 Dec 19;
Further delineation of the SCAF4-associated neurodevelopmental disorder
European journal of human genetics. 2024 Dec 12;
TRIM71 mutations cause a neurodevelopmental syndrome featuring ventriculomegaly and hydrocephalus
Brain. 2024 Dec 03; 147:4292-4305